Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results
Werte in diesem Artikel
Boston Scientific (NYSE:BSX), a maker of medical devices for interventional specialties, closed Monday at $62.92, down 9.03%. The stock moved lower on Monday as investors analyzed new clinical trial information on the company’s Watchman heart implant. Trading volume reached 39.9 million shares, coming in about 163% above its three-month average of 15.2 million shares. Boston Scientific IPO'd in 1992 and has grown 1370% since going public.S&P 500 slipped 0.39% to finish Monday at 6,344, while the Nasdaq Composite declined 0.73% to close at 20,795. Among medical device peers, Medtronic closed at $85.78 (-1.56%) and Stryker ended at $326.05 (-0.42%), reflecting broader pressure across the group.Boston Scientific provided an update on its CHAMPION-AF clinical trial, which tests its Watchman FLX heart implant versus existing oral anticoagulant (NOAC) treatment options. While management announced that the trial met all of its safety and efficacy endpoints, analysts were underwhelmed.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: Boston Scientific und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Boston Scientific
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Boston Scientific
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: MotleyFool